Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)

Clinical trial NCT05687500 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05687500
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Transient; Hypoglycemia, Neonatal Preterm Glibenclamide Adverse Reaction

Start date: 2023-05-20
Primary completion: 2025-10-30
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.